A detailed history of Seizert Capital Partners, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Seizert Capital Partners, LLC holds 7,586 shares of BIIB stock, worth $1.32 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
7,586
Previous 5,155 47.16%
Holding current value
$1.32 Million
Previous $1.11 Million 58.24%
% of portfolio
0.09%
Previous 0.05%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

BUY
$190.52 - $236.72 $463,154 - $575,466
2,431 Added 47.16%
7,586 $1.76 Million
Q1 2024

May 01, 2024

SELL
$212.02 - $267.71 $25,230 - $31,857
-119 Reduced 2.26%
5,155 $1.11 Million
Q4 2023

Feb 07, 2024

BUY
$222.59 - $267.94 $28,046 - $33,760
126 Added 2.45%
5,274 $1.36 Million
Q3 2023

Nov 06, 2023

BUY
$253.3 - $285.89 $355,886 - $401,675
1,405 Added 37.54%
5,148 $1.32 Million
Q2 2023

Jul 27, 2023

SELL
$275.25 - $318.06 $107,347 - $124,043
-390 Reduced 9.44%
3,743 $1.07 Million
Q1 2023

May 09, 2023

BUY
$256.56 - $292.34 $164,198 - $187,097
640 Added 18.32%
4,133 $1.15 Million
Q4 2022

Jan 30, 2023

BUY
$252.44 - $306.72 $881,772 - $1.07 Million
3,493 New
3,493 $967,000
Q1 2022

May 03, 2022

SELL
$193.77 - $244.14 $4.16 Million - $5.24 Million
-21,464 Closed
0 $0
Q4 2021

Feb 08, 2022

BUY
$223.92 - $287.77 $4.4 Million - $5.66 Million
19,655 Added 1086.51%
21,464 $5.15 Million
Q3 2021

Nov 03, 2021

SELL
$282.99 - $369.05 $18,111 - $23,619
-64 Reduced 3.42%
1,809 $512,000
Q2 2021

Aug 05, 2021

SELL
$259.0 - $414.71 $30.1 Million - $48.1 Million
-116,059 Reduced 98.41%
1,873 $649,000
Q1 2021

May 05, 2021

BUY
$242.95 - $284.63 $937,544 - $1.1 Million
3,859 Added 3.38%
117,932 $33 Million
Q4 2020

Feb 08, 2021

SELL
$236.26 - $355.63 $1.94 Million - $2.92 Million
-8,221 Reduced 6.72%
114,073 $27.9 Million
Q3 2020

Nov 03, 2020

BUY
$264.77 - $305.71 $51,365 - $59,307
194 Added 0.16%
122,294 $34.7 Million
Q2 2020

Aug 06, 2020

BUY
$258.66 - $342.55 $2.45 Million - $3.25 Million
9,482 Added 8.42%
122,100 $32.7 Million
Q1 2020

May 05, 2020

SELL
$268.85 - $341.04 $10.9 Million - $13.8 Million
-40,509 Reduced 26.45%
112,618 $35.6 Million
Q4 2019

Feb 10, 2020

SELL
$220.06 - $304.07 $8.66 Million - $12 Million
-39,358 Reduced 20.45%
153,127 $45.4 Million
Q3 2019

Nov 07, 2019

BUY
$217.44 - $243.88 $1.13 Million - $1.26 Million
5,174 Added 2.76%
192,485 $44.8 Million
Q2 2019

Aug 06, 2019

BUY
$219.29 - $241.72 $4.99 Million - $5.5 Million
22,764 Added 13.83%
187,311 $43.8 Million
Q1 2019

May 07, 2019

BUY
$216.71 - $338.96 $13.8 Million - $21.7 Million
63,895 Added 63.48%
164,547 $38.9 Million
Q4 2018

Feb 08, 2019

SELL
$278.5 - $352.75 $1.35 Million - $1.7 Million
-4,832 Reduced 4.58%
100,652 $30.3 Million
Q3 2018

Nov 09, 2018

BUY
$293.51 - $383.83 $2.03 Million - $2.66 Million
6,929 Added 7.03%
105,484 $37.3 Million
Q1 2018

May 10, 2018

BUY
$260.13 - $367.91 $14,307 - $20,235
55 Added 0.06%
98,555 $27 Million
Q4 2017

Feb 12, 2018

SELL
$307.64 - $344.58 $232,268 - $260,157
-755 Reduced 0.76%
98,500 $31.4 Million
Q3 2017

Oct 31, 2017

SELL
$281.15 - $329.69 $1.64 Million - $1.92 Million
-5,821 Reduced 5.54%
99,255 $31.1 Million
Q2 2017

Aug 09, 2017

BUY
N/A
105,076
105,076 $28.5 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Seizert Capital Partners, LLC Portfolio

Follow Seizert Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Seizert Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Seizert Capital Partners, LLC with notifications on news.